Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07760948
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes AssociationNot Yet RecruitingPhase 2
NCT07760948Not Yet Recruiting
Phase 2
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes Associa...
NCT07760701
Description of the Lived Experiences of Family Caregivers for People With Mental Health ComorbiditiesCentre for Infectious Disease Research in ZambiaCompleted
NCT07760701Completed
—
Description of the Lived Experiences of Family Caregivers for People With Mental...Centre for Infectious Dis...
NCT07761455
Prophylactic IABP in Delayed-Presentation Anterior STEMIQilu Hospital of Shandong UniversityNot Yet RecruitingNot Applicable
NCT07761455Not Yet Recruiting
Not Applicable
Prophylactic IABP in Delayed-Presentation Anterior STEMIQilu Hospital of Shandong...
NCT07759973
Neurocomputational Dynamics of CooperationEmory UniversityNot Yet RecruitingNot Applicable
NCT07759973Not Yet Recruiting
Not Applicable
Neurocomputational Dynamics of CooperationEmory University
NCT07759206
Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade MonitoringUniversity of MinnesotaCompletedNot Applicable
NCT07759206Completed
Not Applicable
Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade MonitoringUniversity of Minnesota
NCT07760805
The Use of Holter Monitoring in Children Presented With Arrythmia Symptoms in Sohag University HospitalsMariln Nathan AzerNot Yet Recruiting
NCT07760805Not Yet Recruiting
—
The Use of Holter Monitoring in Children Presented With Arrythmia Symptoms in So...Mariln Nathan Azer
NCT07760649
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic StrokeNeuravi LimitedNot Yet Recruiting
NCT07760649Not Yet Recruiting
—
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in t...Neuravi Limited
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07759622
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcare Provider Trust Using Evidence Informed RecommendationsLund UniversityRecruitingNot Applicable
NCT07759622Recruiting
Not Applicable
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcar...Lund University
NCT07759284
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People's HospitalNot Yet Recruiting
NCT07759284Not Yet Recruiting
—
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People'...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07760675
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Caring for 2 Spirit Metis Patients Using and AI Assisted OSCE.Canadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07760675Not Yet Recruiting
Not Applicable
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Ca...Canadian Institutes of He...
NCT07759479
Effects of the Rebozo Technique During Active Labor on Labor Pain and Labor Duration in Primiparous WomenIstanbul UniversityCompletedNot Applicable
NCT07759479Completed
Not Applicable
Effects of the Rebozo Technique During Active Labor on Labor Pain and Labor Dura...Istanbul University
NCT07759921
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal CancerNational Cancer Institute (NCI)Not Yet RecruitingNot Applicable
NCT07759921Not Yet Recruiting
Not Applicable
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal CancerNational Cancer Institute...
NCT07761416
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer PreventionSt. Joseph's Healthcare HamiltonNot Yet RecruitingEarly Phase 1
NCT07761416Not Yet Recruiting
Early Phase 1
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer Preventi...St. Joseph's Healthcare H...
NCT07761130
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)Health Research Board, IrelandCompletedNot Applicable
NCT07761130Completed
Not Applicable
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke...Health Research Board, Ir...
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07761208
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye UniversityNot Yet Recruiting
NCT07761208Not Yet Recruiting
—
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye University
NCT07760610
Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL After First-Line ResponseThe First Hospital of Jilin UniversityNot Yet RecruitingPhase 4
NCT07760610Not Yet Recruiting
Phase 4
Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL...The First Hospital of Jil...
Result Breakdown
Not yet recruiting13 (65%)
Completed5 (25%)
Recruiting2 (10%)
not_applicable10 (50%)
Not Specified5 (25%)
Phase 22 (10%)
Phase 11 (5%)
Early Phase 11 (5%)
Phase 41 (5%)